Andreas Blesl

ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 10

Top Venues

Journal of clinical medicine

Alimentary pharmacology & therapeutics

Nutrients

Scandinavian journal of gastroenterology

This page only lists publications with an associated author ORCID identifier.

Publications

Andreas Blesl, Philipp Wurm, Silvio Waschina, Hans Peter Gröchenig, Gottfried Novacek, Christian Primas, Walter Reinisch, Maximilian Kutschera, Constanze Illiasch, Barbara Hennlich, Pius Steiner, Robert Koch, Wolfgang Tillinger, Thomas Haas, Gerhard Reicht, Andreas Mayer, Othmar Ludwiczek, Wolfgang Miehsler, Karin Steidl, Lukas Binder, Simon Reider, Christina Watschinger, Stefan Fürst, Patrizia Kump, Alexander Moschen, Konrad Aden, Gregor Gorkiewicz, Christoph Högenauer
Prediction of Response to Systemic Corticosteroids in Active UC by Microbial Composition-A Prospective Multicenter Study. Inflammatory bowel diseases (2023)
Andreas Blesl, Andrea Borenich, Hans Peter Gröchenig, Gottfried Novacek, Christian Primas, Walter Reinisch, Maximilian Kutschera, Constanze Illiasch, Barbara Hennlich, Pius Steiner, Robert Koch, Wolfgang Tillinger, Thomas Haas, Gerhard Reicht, Andreas Mayer, Othmar Ludwiczek, Wolfgang Miehsler, Karin Steidl, Lukas Binder, Franziska Baumann-Durchschein, Stefan Fürst, Simon Reider, Christina Watschinger, Heimo Wenzl, Alexander Moschen, Andrea Berghold, Christoph Högenauer, null null
Factors Associated with Response to Systemic Corticosteroids in Active Ulcerative Colitis: Results from a Prospective, Multicenter Trial. Journal of clinical medicine 12 (14) (2023)
Andreas Blesl, Wolfgang Petritsch, Lukas Binder, Stefan Fürst, Heimo Wenzl, Franziska Baumann-Durchschein, Patrizia Kump, Christoph Högenauer
Treatment persistence of ustekinumab and vedolizumab in IBD patients is independent of prior immunogenicity to anti-TNFs: a retrospective study. Scandinavian journal of gastroenterology 57 (11) (2022)
Simon Reider, Lukas Binder, Stefan Fürst, Stefan Hatzl, Andreas Blesl
Hematopoietic Stem Cell Transplantation in Refractory Crohn's Disease: Should It Be Considered? Cells 11 (21) (2022)
Andreas Blesl, Lukas Binder, Christoph Högenauer, Heimo Wenzl, Andrea Borenich, Gudrun Pregartner, Andrea Berghold, Sigrid Mestel, Patrizia Kump, Franziska Baumann-Durchschein, Wolfgang Petritsch
Limited long-term treatment persistence of first anti-TNF therapy in 538 patients with inflammatory bowel diseases: a 20-year real-world study. Alimentary pharmacology & therapeutics 54 (5) (2021)
Andreas Blesl, Vanessa Stadlbauer
The Gut-Liver Axis in Cholestatic Liver Diseases. Nutrients 13 (3) (2021)
Andreas Blesl, Christoph Högenauer, Andrea Borenich, Andrea Berghold, Heimo Wenzl, Wolfgang Petritsch
Editorial: does anti-TNF 'treatment persistence' always equate to 'effective treatment'? Only objective disease assessments can answer the question. Authors' reply. Alimentary pharmacology & therapeutics 54 (5) (2021)
Andreas Blesl, Martin Eibisberger, Michael Schörghuber, Christoph Klivinyi, Vanessa Stadlbauer
High Rate of Gastrointestinal Bleeding in Patients with Secondary Sclerosing Cholangitis in Critically Ill Patients (SC-CIP). Journal of clinical medicine 10 (9) (2021)
Andreas Blesl, Iva Brcic, Werner Jaschke, Dietmar Öfner, Peter Fickert, Johannes Plank
Chronic gastric ulcer disease complicating selective internal radiation therapy (SIRT) in a patient with cholangiocellular carcinoma. Zeitschrift fur Gastroenterologie 57 (11) (2019)
Andreas Blesl, Florian Rainer, Marion Pollheimer, Patrizia Kump, Franziska Durchschein, Heimo Wenzl, Kathrin Eller, Peter Krisper, Wolfgang Petritsch, Christoph Högenauer
Successful Pregnancies After Regression of AA Amyloidosis by Anti-inflammatory Therapy in Chronic Active Crohn's Disease. Digestive diseases and sciences 65 (9) (2019)

Andreas Blesl.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Andreas Blesl